203
Views
33
CrossRef citations to date
0
Altmetric
Vaginal Atrophy

High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy

, , , , , , , , , , , , , , , & show all
Pages 524-532 | Received 19 Aug 2009, Accepted 12 Oct 2009, Published online: 12 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

P. Stute, S. Bertschy, M. Birkhaeuser, J. Bitzer, A. Ging, A. Raggi, S. Steimann & V. Stute. (2022) Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause. Climacteric 25:3, pages 246-256.
Read now
Soheila Nazarpour, Masoumeh Simbar & Fahimeh Ramezani Tehrani. (2019) Sexual Function in Postmenopausal Women and Serum Androgens: A Review Article. International Journal of Sexual Health 31:3, pages 244-256.
Read now
Pamela CMD Zanni, Melyssa Negri, Tânia P Salci, Patrícia de S Bonfim-Mendonça, Érika S Kioshima, Terezinha IE Svidzinski & Márcia EL Consolaro. (2014) Animal models for the effective development of atrophic vaginitis therapies: possibilities and limitations. Expert Opinion on Drug Discovery 9:3, pages 269-281.
Read now

Articles from other publishers (30)

Katarzyna Tomczyk, Karolina Chmaj-Wierzchowska, Katarzyna Wszołek & Maciej Wilczak. (2023) New Possibilities for Hormonal Vaginal Treatment in Menopausal Women. Journal of Clinical Medicine 12:14, pages 4740.
Crossref
Łukasz Nowakowski, Krzysztof Gałczyński, Michał Dybowski, Rafał Typek, Andrzej Dawidowicz, Paweł Miotła, Piotr Olcha & Tomasz Rechberger. (2023) Effects of topical dehydroepiandrosterone therapy in women after pelvic organ prolapse surgery. Menopause 30:6, pages 629-634.
Crossref
S. Vandamme, N. Willers & S. Han. (2022) Lokaal gebruik van dehydro-epiandrosteron voor de behandeling van vaginale atrofie na borstkanker. Tijdschrift voor Geneeskunde.
Crossref
Lucia A. da SILVA LARA, Andrea C. RUFINO, Flávia F. OLIVEIRA, Serena ROSSATO, Charles S. BORGES & Rosana M. REIS. (2022) Female sexual dysfunctions: an overview on the available therapeutic interventions. Minerva Obstetrics and Gynecology 74:3.
Crossref
Petra Stute. (2022) Die Rolle von vaginalem DHEA bei der Behandlung des genitourinären Syndroms der MenopauseLe rôle de la DHEA vaginale dans le traitement du syndrome génito-urinaire de la ménopause. Journal für Gynäkologische Endokrinologie/Schweiz 25:2, pages 87-100.
Crossref
Abbie J. Laing, Louise Newson & James A. Simon. (2022) Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development. The Cancer Journal 28:3, pages 196-203.
Crossref
Swati SwatiDr.Dr., Rakhi KumariDr.Dr. & Minu SharanDrDr. (2021) EFFECT OF INTRAVAGINAL DEHYDROEPIANDROSTERONE IN REDUCING POSTMENOPAUSAL SYMPTOMS. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 67-68.
Crossref
Monica Michelle Christmas, Bonnie Song, Robin J. Bell, Stamatina Iliodromiti, Caroline Mitchell & Martha Hickey. (2020) Variation in outcome reporting and measurement tools in clinical trials of treatments for genitourinary symptoms in peri- and postmenopausal women: a systematic review. Menopause 27:9, pages 1070-1080.
Crossref
Suneela VeguntaJuliana M. KlingEkta Kapoor. (2020) Androgen Therapy in Women. Journal of Women's Health 29:1, pages 57-64.
Crossref
Mollie Parker Szybala & Cory Szybala. 2020. Textbook of Natural Medicine. Textbook of Natural Medicine 1840 1849.e4 .
Suneela VeguntaJulia FilesJuliana M. Kling. (2019) Newer Name, Newer Treatments: The Genitourinary Syndrome of Menopause. Journal of Women's Health 28:7, pages 897-899.
Crossref
Joanie Mercier, Mélanie Morin, Barbara Reichetzer, Marie-Claude Lemieux, Samir Khalifé & Chantale Dumoulin. (2019) Genitourinary syndrome of menopause symptom severity and impact outcome measures: are they reliable and correlated?. Menopause 26:6, pages 659-664.
Crossref
No Author. (2019) Chapitre 5 : Santé urogénitale. Journal of Obstetrics and Gynaecology Canada 41, pages S73-S81.
Crossref
Susan R. Davis, Roisin Worsley, Karen K. Miller, Sharon J. Parish & Nanette Santoro. (2016) Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine. The Journal of Sexual Medicine 13:2, pages 168-178.
Crossref
Malgorzata E. Skaznik-Wikiel, Michael L. Traub & Nanette Santoro. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric 2310 2322.e4 .
Carola S Scheffers, Sarah Armstrong, Astrid EP Cantineau, Cindy Farquhar & Vanessa Jordan. (2015) Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Cochrane Database of Systematic Reviews 2015:1.
Crossref
M. A. Weber, J. Limpens & J. P. W. R. Roovers. (2014) Assessment of vaginal atrophy: a review. International Urogynecology Journal 26:1, pages 15-28.
Crossref
Andrea Salonia, Giulia Castagna & Francesco Montorsi. 2015. Clinical Uro-Andrology. Clinical Uro-Andrology 147 168 .
Jonathan Bertin, Johanne Ouellet, Alain Yves Dury, Georges Pelletier & Fernand Labrie. (2014) Expression of the estrogen receptors and steroidogenic enzymes involved in estradiol formation in the monkey vagina. American Journal of Obstetrics and Gynecology 211:5, pages 499.e1-499.e9.
Crossref
Amber N. McLendon, Valerie B. Clinard & C. Brock Woodis. (2014) Ospemifene for the Treatment of Vulvovaginal Atrophy and Dyspareunia in Postmenopausal Women. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:10, pages 1050-1060.
Crossref
. (2014) RETIRED: Managing Menopause Chapter 5 Urogenital Health. Journal of Obstetrics and Gynaecology Canada 36:9, pages S35-S41.
Crossref
Claudine Domoney. (2014) Treatment of Vaginal Atrophy. Women's Health 10:2, pages 191-200.
Crossref
Petra M Casey. (2014) Caring for the breast cancer survivor’s health and well-being. World Journal of Clinical Oncology 5:4, pages 693.
Crossref
. (2013) Management of symptomatic vulvovaginal atrophy. Menopause 20:9, pages 888-902.
Crossref
Annamaria Giraldi, Alessandra H. Rellini, James Pfaus & Ellen Laan. (2013) Female Sexual Arousal Disorders. The Journal of Sexual Medicine 10:1, pages 58-73.
Crossref
Mary Panjari & Susan R. Davis. (2011) Vaginal DHEA to treat menopause related atrophy: A review of the evidence. Maturitas 70:1, pages 22-25.
Crossref
. (2011) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 18:3, pages 231-234.
Crossref
Rachna M Goel & Anne R Cappola. (2011) Dehydroepiandrosterone sulfate and postmenopausal women. Current Opinion in Endocrinology, Diabetes & Obesity 18:3, pages 171-176.
Crossref
Sabrina WitherbyJulia JohnsonLaurence DemersSharon MountBenjamin LittenbergCharles D. MacleanMarie WoodHyman Muss. (2011) Topical Testosterone for Breast Cancer Patients with Vaginal Atrophy Related to Aromatase Inhibitors: A Phase I/II Study. The Oncologist 16:4, pages 424-431.
Crossref
Rossella E Nappi, Francesca Albani, Valentina Santamaria, Silvia Tonani, Ellis Martini, Erica Terreno, Emanuela Brambilla & Franco Polatti. (2010) Menopause and sexual desire: the role of testosterone. Menopause International 16:4, pages 162-168.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.